Pharmaceutical Mail. Ten years ago, Accord's parent company, Intas, arrived in Spain, and five years ago the Spanish subsidiary of this Indian laboratory was born, which decided to make the leap from manufacturing to third parties and start operating under its own name. "It can be said that five years ago we did not exist and now we are a benchmark in hospital pharmacy," the general director of Accord Spain, Marc Comas, told CF. In Spain, the multinational hopes to close the year by doubling its turnover compared to the past, which amounted to 15 million euros, and which is an amount that would have already been reached in the first six months: "In Europe Accord wants to reach 160 million euros in 2015; in Spain we will pass thirty'.